Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4161/mabs.29105 http://scihub22266oqcxt.onion/10.4161/mabs.29105 C4171018!4171018!24866199     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=24866199&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       MAbs 2014 ; 6 (4): 820-37 Nephropedia Template TP {{tp|p=24866199|t=2014. Rituximab: How approval history is reflected by a corresponding patent filing strategy |pdf=|usr=}}{{24866199}} gab.com Text Rituximab: How approval history is reflected by a corresponding patent filing strategy JO: MAbs http://www.kidney.de/pget.php?&tw=1&pmid=24866199 #FOAvip Because drug development is not a static process, a drug?s market authorisation may change over time. In many cases, the number of indications for which a drug is approved increases. Because this facet of drug development also comes at significant costs, a corresponding patent filing strategy is required to protect these investments. The strategy as applied to rituximab, which is approved for a variety of indications, is discussed in this review. Twit Text FOAVip Rituximab: How approval history is reflected by a corresponding patent filing strategy ????MAbs http://www.kidney.de/pget.php?&tw=1&pmid=24866199 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24866199 #FOAvip English Wikipedia <ref>{{Cite pmid|24866199}}</ref> Rituximab: How approval history is reflected by a corresponding patent filing strategy #MMPMID24866199 Storz U MAbs 2014[Jul]; 6 (4): 820-37 PMID24866199show ga Because drug development is not a static process, a drug?s market authorisation may change over time. In many cases, the number of indications for which a drug is approved increases. Because this facet of drug development also comes at significant costs, a corresponding patent filing strategy is required to protect these investments. The strategy as applied to rituximab, which is approved for a variety of indications, is discussed in this review. äRituximab: How approval history is reflected by a corresponding patent(epmc).pdf DeepDyve Pubget Overpricing